Tus-Pharmaceutical Group Co., Ltd.

符号: 000590.SZ

SHZ

6.8

CNY

今天的市场价格

155.0687
市盈率
2.6708
PEG比率
1.63B
MRK市值
0.00%
DIV收益率

Tus-Pharmaceutical Group Co., Ltd. (000590-SZ) 财务报表

Q: 什么是 Tus-Pharmaceutical Group Co., Ltd. (000590.SZ) 总资产是多少？

Tus-Pharmaceutical Group Co., Ltd. (000590.SZ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Tus-Pharmaceutical Group Co., Ltd. (000590.SZ). 的默认数据。公司收入显示 242.141 M 的平均值，即 0.135 % 增长率。整个期间的平均毛利润为 119.874 M，即 0.151 %. 平均毛利率为 0.481 %. 公司去年的净收入增长率为 0.394 %，等于 -0.051 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Tus-Pharmaceutical Group Co., Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 -0.013. 在流动资产领域，000590.SZ 的报告货币为539.552. 这些资产中的很大一部分，即 189.77 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.272%. 公司的长期投资虽然不是其重点，但以报告货币计算的44.615（如果有的话）为44.615。这表明与上一报告期相比，-830.366% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 80. 这一数字表明，-0.001% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 723.718. 这方面的年同比变化率为 0.036%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为215.015，存货估值为 130.09，商誉估值为 131.64（如有. 无形资产总额（如果有）按 132.33 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
balance-sheet.row.cash-and-short-term-investments	767.96	189.8	260.5	325.8	343	314.3	321.4	124.3	122.7	55.8	47.8	65.7	158.9	27.7	8.8	13.9	16.4	25	22.8	38.7	17.7	11.4	41.5	28.8	47	53.6	18.4	26.4	14.3	5.2
balance-sheet.row.short-term-investments	31.67	0	25.1	75.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.2	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	756.24	215	147.8	141.5	114.2	125.9	66.9	141	95	115.3	145	110.2	176.9	123	162.8	163.4	208.7	295.4	349.8	262.2	272.6	252.9	228.4	273	9.2	1.8	4	6	3.3	0.8
balance-sheet.row.inventory	528.48	130.1	118.2	86.6	50.8	50.9	69	63.4	66.7	69.2	42	64.3	70.4	87.5	86.4	63	77	55.2	37.2	82.8	91.5	109.5	121.3	124.4	83.7	87.5	50.9	46	12	16.7
balance-sheet.row.other-current-assets	18.97	4.7	2.6	0	0.6	0.3	29.7	193.6	0	-1.8	20.1	40	-15.4	-8.8	-22.7	-36.4	-41.8	-78.2	-46.7	-26.7	-23.3	-22.6	-20.6	-28.5	213.6	170.3	166.5	140.4	78.3	63.1
balance-sheet.row.total-current-assets	2071.65	539.6	529.1	553.9	508.6	491.5	487	522.3	284.4	238.6	255	280.2	390.8	229.4	235.4	203.9	260.4	297.4	363.1	357	358.4	351.1	370.6	397.6	353.5	313.2	239.7	218.8	107.9	85.8
balance-sheet.row.property-plant-equipment-net	1172.35	293.8	289.7	240.9	224.7	201	171.3	164.8	157.8	151.6	162	122.4	178.5	177.6	153.8	135.4	129.8	128.1	129.5	215.4	212.3	219.4	254.4	248.8	212.8	195.6	126.2	117.7	55.6	42.2
balance-sheet.row.goodwill	537.58	131.6	137.1	0	0	0	0	0	7.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	570.87	132.3	157.4	133.7	138.2	134.7	137.6	167.9	171.5	191.2	156.1	145.9	131.6	134.1	136.6	139.1	141.8	85.1	16	56.5	66.7	76.1	92	39.6	53.8	50.2	12.3	12	5.5	4.6
balance-sheet.row.goodwill-and-intangible-assets	1108.45	264	294.6	133.7	138.2	134.7	137.6	167.9	178.7	191.2	156.1	145.9	131.6	134.1	136.6	139.1	141.8	85.1	16	56.5	66.7	76.1	92	39.6	53.8	50.2	12.3	12	5.5	4.6
balance-sheet.row.long-term-investments	95.12	44.6	-6.1	-56.1	15.7	14.5	0	0	4.8	0	1.1	0	0	0	0	0	0	0	35.5	34.6	38	37	5.9	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	17.36	4.1	5	5	4.6	2.1	2.4	2.9	3.4	4	4.6	1.4	0	0	0	0	5.2	6.5	0.9	1	1.2	1.4	1.7	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	91.31	5.1	54.5	90.5	0.3	2.9	18.3	15.9	1.6	2.1	8.1	2.6	3	61.2	42.9	38	34.1	31.6	0.4	0	0	0	0.1	9.1	16.1	37.9	26.1	24.7	18.4	8.5
balance-sheet.row.total-non-current-assets	2484.59	611.6	637.6	413.9	383.5	355.3	329.6	351.4	346.3	348.8	331.8	272.3	313.2	373	333.3	312.5	310.9	251.2	182.2	307.6	318.2	334	354.3	297.5	282.8	283.7	164.6	154.4	79.5	55.3
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	4556.24	1151.1	1166.8	967.8	892.2	846.7	816.6	873.7	630.7	587.4	586.8	552.6	704	602.5	568.7	516.3	571.3	548.6	545.4	664.6	676.6	685.2	724.9	695	636.3	596.9	404.3	373.2	187.5	141.1
balance-sheet.row.account-payables	228.31	47.6	64	41.7	38.6	34.9	26.6	44.3	41.7	41.6	46.7	86.3	83.3	73.3	78.4	67.5	72	47	54.1	70.9	84.5	87.6	110.9	92.5	66	69	42.9	28.4	2.8	5.6
balance-sheet.row.short-term-debt	146.92	50.6	38.6	3	5	-28.9	18	0	78.3	64	77.5	0	0	62.6	67.7	105.1	96	123.8	153.5	225.9	236.8	252.3	230.6	228.2	73.6	79.6	38.3	26.8	11.4	19.1
balance-sheet.row.tax-payables	17	2.3	16.8	8	7.4	14.2	4.6	17	10.3	3.4	3.3	25.5	52.8	41	37.3	35.2	24.5	21.5	20.4	19.8	23.4	18	18	11.8	17.6	6.9	6.4	7.9	5.5	7.7
balance-sheet.row.long-term-debt-total	350.5	80	95.2	5.6	9.2	0	20	20	0	0	73.1	-7	0	0	0	10	14	0	0	15.5	15.5	19.9	22.1	24.3	35.5	17.2	28.6	31.9	9	10.8
Deferred Revenue Non Current	170.73	42.4	44.4	46.3	41.6	38.7	39	37.8	36.1	31.3	8.7	7	0	0	0	0	-14	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	25.76	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	211.71	100.4	112.7	9.6	1.8	119	91.9	120.3	57.9	87	87.7	186.3	132.4	22	43.9	12	9.4	16.8	13	19.7	12.2	13	10.4	0.9	0	2.1	25.9	8.1	21.4	2.3
balance-sheet.row.total-non-current-liabilities	694.78	131.7	192.8	98.5	86.3	70.7	95.9	125.8	112.1	116.8	84.5	10.4	9.7	2.6	2.7	12.6	14.1	8	7.7	15.5	15.5	19.9	22.1	24.3	35.5	15.2	28.5	31	10	11.9
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-7.7	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	18.3	3.1	5.2	5.6	9.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	1647.66	380.5	464.3	285.5	247.3	224.6	236.9	290.4	366.7	381.6	402.7	283.1	225.4	251.6	289.8	285.1	248.5	241.4	274.1	396	409.1	426	444	416.4	256.2	249.1	135.6	132.2	45.5	75.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	957.89	239.5	239.5	239.5	239.5	239.5	239.5	239.5	223.3	223.3	223.3	223.3	223.3	203	203	203	203	203	203	203	203	203	203	203	203	112.8	102.6	102.6	72	50
balance-sheet.row.retained-earnings	-188.84	-35.7	-61	-79.1	-114.6	-137.3	-179.7	-141.5	-160.7	-215.9	-238.3	-152.5	56.6	-16.9	-89.1	-109.3	-17.3	-37.7	-68.5	-71.4	-75.6	-81.1	-54.4	-58.5	27.7	37.8	46.9	23.2	2.7	0.2
balance-sheet.row.accumulated-other-comprehensive-income-loss	1325.12	142.6	142.6	142.6	142.6	142.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	754.73	377.4	377.4	377.4	377.4	377.4	520	485.4	198.3	198.3	199	198.7	198.6	175.2	175.4	137.5	137.1	141.9	136.7	137.5	140.1	136.5	135.2	135.4	144.6	196.6	119.2	115.1	67.2	15.1
balance-sheet.row.total-stockholders-equity	2848.9	723.7	698.5	680.3	644.9	622.2	579.7	583.3	261	205.8	184.1	269.5	478.6	361.3	289.3	231.2	322.8	307.2	271.3	269.2	267.5	258.5	283.8	279.9	375.3	347.2	268.8	240.9	141.9	65.3
balance-sheet.row.total-liabilities-and-stockholders-equity	4556.24	1151.1	1166.8	967.8	892.2	846.7	816.6	873.7	630.7	587.4	586.8	552.6	704	612.9	579.2	516.3	571.3	548.6	545.4	664.6	676.6	685.2	724.9	695	636.3	596.9	404.3	373.2	187.5	141.1
balance-sheet.row.minority-interest	17.24	4.5	4	2	0	0	0	0	3	0	0	0	0	0	0	-0.5	0	0	0	-0.6	0.1	0.7	-2.9	-1.3	4.7	0.6	0	0	0	0
balance-sheet.row.total-equity	2866.14	728.2	702.5	682.3	644.9	622.2	579.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	4556.24	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	126.79	44.6	19	19	15.7	14.5	0	1.6	4.8	0	1.1	2.6	2.6	60.1	41	35.2	30.3	30.3	35.6	34.7	38.1	37.1	6.1	7.1	10.5	27.1	25.6	3.7	3.7	0
balance-sheet.row.total-debt	505.22	133.7	133.8	8.6	5	0	38	20	78.3	64	77.5	0	0	62.6	67.7	115.1	110	123.8	153.5	241.4	252.3	272.2	252.8	252.5	109.2	96.8	66.9	58.7	20.4	29.9
balance-sheet.row.net-debt	-207.74	-56.1	-101.6	-242.1	-338	-314.3	-283.4	-104.3	-44.4	8.1	29.7	-65.7	-158.9	34.9	58.9	101.2	93.6	98.9	130.8	202.8	234.7	261	211.4	223.7	62.1	43.3	48.6	32.3	6.2	24.7

现金流量表

在 Tus-Pharmaceutical Group Co., Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -2.409 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到4158530.000. 与上一年相比， -1.023 发生了变化. 在同一时期，公司记录了 28.26, 0 和 -25，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-4.2 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -3.32，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	10.38	25.2	18.2	35.4	22.7	42.4	-38.2	9.9	50.1	22.4	-85.8	-164.5	137.6	72.1	47.2	-88.2	20.4	20.5	1.9	3.6	4.8	-27.7	1.5	-63.2	30.2	12.5	27.8
cash-flows.row.depreciation-and-amortization	0.25	28.3	24.4	19.5	14.2	14.3	16.1	14.3	14.6	14	13.3	16.8	16.8	15	13.8	13.9	12.6	16.5	24.7	26.5	26.9	27.7	20.5	16.6	8.4	10	9.9
cash-flows.row.deferred-income-tax	0	-0.4	0.9	-0.4	-2.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	-142.3	-0.9	0.4	2.4	-0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-49.51	-85.8	12	-27.1	12.4	-9.6	18.6	-113.5	-59.1	-102.6	8.6	80.6	3.1	-62.2	20	7.3	-8.2	14.1	-89.2	2.7	-6.3	-38.6	58.2	-31.6	-50.3	33.3	-43.4
cash-flows.row.account-receivables	-45.83	-45.8	2.9	-26.8	-0.5	-59.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-11.64	-11.6	-7.3	-35.6	-0.4	17	-6.6	1.1	3.7	-30.1	21.7	-13.2	15.5	-1.7	-23.2	11.9	-22.2	-17.9	-42.4	8.9	16.1	11.4	3.1	-27.7	3.8	-36.8	-4.9
cash-flows.row.account-payables	0	-28.3	15.5	35.7	15.7	32.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	7.96	0	0.9	-0.4	-2.4	0.3	25.1	-114.6	-62.7	-72.6	-13.1	93.9	-12.4	-60.6	43.2	-4.7	14.1	32.1	-46.8	-6.2	-22.4	-50	55.1	-3.9	-54.1	70.1	-38.5
cash-flows.row.other-non-cash-items	39.37	146.6	-0.1	-2.6	2.2	-18	4.2	0.1	-38.2	5.7	13	71.2	-137.8	5.9	4	101.1	10	16.9	39.2	23.2	23.1	14.3	14.1	27.2	20	-66.1	9.5
cash-flows.row.net-cash-provided-by-operating-activities	0.49	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-19.62	-22	-18.7	-25.9	-33.9	-35.8	-22.6	-23.9	-16.6	-30.1	-87.4	-15	-15.3	-22.7	-24.9	-18.9	-14	-2.1	-1.1	-15.5	-7.3	-11.1	-68	-43.4	-28.7	-15.1	-9.3
cash-flows.row.acquisitions-net	1.41	1.2	-214.5	2.7	0.2	47.1	0	15.5	-3.6	0.8	0.2	0	0	0	0	0	0.1	0	0	0.4	0	11.2	0	0	0	15.2	9.4
cash-flows.row.purchases-of-investments	-309.9	-391.9	-826.5	-1096.7	-60	-0.4	-196.5	-387.1	-27.1	-10	-182	-40	0	0	0	0	-5	0	0	-2	0	-0.1	0	-2.4	0	-3.9	-5.6
cash-flows.row.sales-maturities-of-investments	330.26	416.9	879.5	1005.8	60.4	1.9	396.6	197.2	27.1	33	209.4	0	182.1	0	0.1	0.1	5.2	13	12.6	0	0.1	0.3	0	0.6	0	0.1	1.5
cash-flows.row.other-investing-activites	55.38	0	2.7	-2	5.6	-5.6	3	5.1	72.3	37.6	21.7	0	27	0.5	0.1	-3.5	-5.4	-9.8	0	7.3	0.2	-11.1	0.1	-24.2	0.1	-15.1	-9.3
cash-flows.row.net-cash-used-for-investing-activites	2.16	4.2	-177.5	-116	-27.7	7.2	180.5	-193.1	52	31.3	-38.1	-55	193.8	-22.1	-24.6	-22.3	-19	1.1	11.6	-9.7	-6.9	-10.9	-67.9	-69.4	-28.5	-18.9	-13.4
cash-flows.row.debt-repayment	-69.64	-25	-18	-5	-5	-38	-12	-20	-30	-40	-25.5	-19.2	-128.5	-40	-82.7	-52.5	-123.8	-170.4	-21.5	-69	-143.3	-224.4	-221.9	-39.3	-32.9	-24.8	-73.6
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-4.11	-4.2	-0.3	-0.1	-0.1	-1.4	-1.4	-1.1	-1	-1.7	-3.5	-45	-20.8	-3.8	-5.5	-6.4	-10.5	-15.2	-16	-15.7	-16.3	-13.7	-14.3	-13.1	-14.2	-8.8	-6.6
cash-flows.row.other-financing-activites	-4.26	-3.3	129.9	-0.7	10	-1.4	30	300.2	78.3	79	103	19.2	66.9	53.9	24.2	54.5	98.5	118.7	33.3	59.6	124.4	243.3	222.4	155	61	97.9	81.7
cash-flows.row.net-cash-used-provided-by-financing-activities	-27.64	-32.5	111.5	-5.8	4.9	-39.4	16.6	279.1	47.3	37.2	74	-45	-82.4	10.1	-63.9	-4.4	-35.8	-66.9	-4.2	-25.2	-35.2	5.1	-13.8	102.6	13.8	64.4	1.5
cash-flows.row.effect-of-forex-changes-on-cash	4.73	11.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-21.85	-45.7	-11.5	-96.6	28.6	-3	197.8	-3.1	66.8	8	-15	-96	131.2	18.8	-3.6	7.4	-19.9	2.2	-15.9	21	6.3	-30.2	12.6	-17.9	-6.5	35.2	-8
cash-flows.row.cash-at-end-of-period	704.39	189.8	234.8	246.4	343	314.3	317.4	119.5	122.7	55.8	47.8	62.9	158.8	27.6	8.8	12.4	5	25	22.8	38.7	17.7	11.4	41.4	28.8	47	53.6	18.4
cash-flows.row.cash-at-beginning-of-period	726.24	235.4	246.4	343	314.3	317.4	119.5	122.7	55.8	47.8	62.9	158.8	27.6	8.8	12.4	5	25	22.8	38.7	17.7	11.4	41.5	28.8	46.6	53.6	18.4	26.4
cash-flows.row.operating-cash-flow	0.49	-28.4	54.5	25.2	51.5	29.2	0.7	-89.1	-32.5	-60.6	-50.9	4.1	19.7	30.9	85	34.1	34.9	68	-23.3	56	48.5	-24.4	94.3	-51	8.2	-10.3	3.9
cash-flows.row.capital-expenditure	-19.62	-22	-18.7	-25.9	-33.9	-35.8	-22.6	-23.9	-16.6	-30.1	-87.4	-15	-15.3	-22.7	-24.9	-18.9	-14	-2.1	-1.1	-15.5	-7.3	-11.1	-68	-43.4	-28.7	-15.1	-9.3
cash-flows.row.free-cash-flow	-19.13	-50.4	35.8	-0.7	17.6	-6.6	-21.9	-113	-49.1	-90.7	-138.3	-10.9	4.5	8.2	60.1	15.3	20.9	65.9	-24.4	40.5	41.2	-35.6	26.3	-94.4	-20.5	-25.4	-5.4

利润表行

Tus-Pharmaceutical Group Co., Ltd. 的收入与上期相比变化了 0.130%。据报告, 000590.SZ 的毛利润为 189.87。该公司的营业费用为 183.77，与上年相比变化了 12.737%. 折旧和摊销费用为 28.26，与上一会计期间相比变化了 0.153%. 营业费用报告为 183.77，显示12.737% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.731%. 营业收入为 6.1，与上年相比变化了-0.731%. 净利润的变化率为 0.394%。去年的净收入为25.25.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992
income-statement-row.row.total-revenue	376.25	395.9	350.5	300.8	275.1	315	185.8	343.5	317.4	294.7	203.1	256	363.4	343.5	311.6	274.1	236.6	207.9	286.8	271.1	267.1	238.2	296.6	245.7	283.6	219.6	198.3	133.9	69.1	93.8	74.6	62.7	32.3
income-statement-row.row.cost-of-revenue	186.52	206.1	171.3	134.5	121.8	147.4	98.1	150.7	150.6	132	98.2	125.5	178	150.2	133.7	131	115.9	101.2	181.9	139.3	137.9	140.5	187.8	151.3	139.7	107.8	113.6	74.3	36.4	54.1	43	37.6	21.3
income-statement-row.row.gross-profit	189.73	189.9	179.2	166.3	153.3	167.7	87.8	192.8	166.8	162.8	104.9	130.5	185.5	193.3	177.9	143.1	120.7	106.8	104.9	131.8	129.2	97.7	108.8	94.4	143.8	111.8	84.7	59.6	32.7	39.8	31.6	25.1	11
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	12.12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	16.01	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	86.86	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-6.43	0.1	73.1	68.6	74.5	62.9	-0.6	-0.2	49.7	1.9	-16.4	-37	-1.5	4	-5.1	-1.5	4.8	-3.7	-1	-1.9	-0.6	-8.7	-0.5	-5	10	0.2	6.9	-0.4	-0.4	0	-0.1	-0.2	-0.1
income-statement-row.row.operating-expenses	203.26	183.8	163	132.2	130.9	139.9	123.5	176.2	142.1	127.1	164.5	191.9	138.5	102.2	110.3	116.2	79.8	56.1	81.1	105.5	105	103.9	95.6	131.9	109.9	88.7	55.1	30	17.6	18.5	14	14.2	7
income-statement-row.row.cost-and-expenses	389.78	389.8	334.3	266.7	252.7	287.3	221.6	327	292.6	259.1	262.8	317.4	316.5	252.5	244	247.2	195.7	157.3	263	244.8	242.9	244.3	283.4	283.1	249.6	196.6	168.7	104.3	54	72.6	57	51.8	28.4
income-statement-row.row.interest-income	2.51	2.2	3.4	4.3	4.5	3.7	1.5	0.7	0.2	0.2	0.3	3.2	0.3	0.1	0.2	0.2	0	0.2	0.1	0.1	0.1	0.2	0.9	0.7	1.7	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	4.36	4.5	1.2	0.5	0	1.6	1.5	0.6	2.8	4.2	3.5	0.4	3.1	5.2	8	9.1	13.6	14.5	20.6	17.9	16.3	14.6	15	11.3	7.1	8.2	6.7	2.4	0	1.8	2	1.8	0.7
income-statement-row.row.selling-and-marketing-expenses	86.86	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	28.98	23.6	-0.8	-0.5	-0.1	17.3	-0.1	5.5	41.5	-4.8	-28.1	-104.1	137.3	-3.1	-11.8	-103	-13.4	-19	-21.8	-25.1	-22	-26.5	-15.6	-29.8	-3.8	-8.4	2.9	-1.3	3.3	-1.2	-1.4	-1.8	-0.8
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-6.43	0.1	73.1	68.6	74.5	62.9	-0.6	-0.2	49.7	1.9	-16.4	-37	-1.5	4	-5.1	-1.5	4.8	-3.7	-1	-1.9	-0.6	-8.7	-0.5	-5	10	0.2	6.9	-0.4	-0.4	0	-0.1	-0.2	-0.1
income-statement-row.row.total-operating-expenses	28.98	23.6	-0.8	-0.5	-0.1	17.3	-0.1	5.5	41.5	-4.8	-28.1	-104.1	137.3	-3.1	-11.8	-103	-13.4	-19	-21.8	-25.1	-22	-26.5	-15.6	-29.8	-3.8	-8.4	2.9	-1.3	3.3	-1.2	-1.4	-1.8	-0.8
income-statement-row.row.interest-expense	4.36	4.5	1.2	0.5	0	1.6	1.5	0.6	2.8	4.2	3.5	0.4	3.1	5.2	8	9.1	13.6	14.5	20.6	17.9	16.3	14.6	15	11.3	7.1	8.2	6.7	2.4	0	1.8	2	1.8	0.7
income-statement-row.row.depreciation-and-amortization	11.55	28.3	24.5	20.6	15.9	14.3	16.1	14.3	14.6	14	13.3	16.8	16.8	15	13.8	13.9	12.6	16.5	24.7	26.5	26.9	27.7	20.5	16.6	8.4	10	9.9	0.8	-3.8	1.2	1.2	1.6	0.7
income-statement-row.row.ebitda-caps	-3.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-14.64	6.1	22.7	42.4	27.8	36.2	-35.3	22.3	17	29.1	-69.8	-128.5	186.1	84.2	61.7	-71.8	22.6	35.3	2.3	3	2.9	-24.2	-1.9	-62.1	37.2	15	26.1	28.8	18.9	20.1	16.3	9.3	3.3
income-statement-row.row.income-before-tax	14.34	29.7	21.9	41.8	27.6	53.4	-35.9	22.1	66.2	30.9	-87.8	-165.5	184.2	87.9	55.9	-76.1	27.4	31.6	1.7	1.2	2.3	-32.8	-2.4	-67.2	38.7	14.9	32.8	28.4	18.4	20.1	16.2	9.1	3.2
income-statement-row.row.income-tax-expense	4.32	4.8	3.7	6.4	4.9	11	2.3	12.2	16.1	8.5	-2	-1.1	46.6	15.8	8.7	12.1	7.1	11.1	0.1	0.2	0.2	0.1	0.1	0.1	8.5	2.5	4.9	4.3	2.8	6.6	1.2	1	0.6
income-statement-row.row.net-income	10.38	25.2	18.1	35.4	22.7	42.4	-38.2	19.2	55.2	22.4	-85.8	-164.5	137.6	72.1	47.2	-88.2	20.4	20.5	2.9	4.3	5.4	-26.2	4.1	-59.7	30.3	12.5	27.9	24.1	15.6	13.5	15	8.1	2.6